GLP-1 Drugs Show Promise in Lowering Epilepsy Risk Among Diabetes Patients
A groundbreaking study published in Neurology and reported by Drugs.com reveals that adults with type 2 diabetes who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs), a class of medications increasingly…